Oncology & Cancer

Two genes slow down the development of intestinal tumors

Benign intestinal tumors with mutations that delete or inactivate two particular tumor-suppressing genes develop more quickly towards cancerous forms, according to new research from the Crick.

Oncology & Cancer

A new way to stop cancer cells from killing their healthy neighbors

One of the reasons cancer cells are so robust against the body's natural defenses is that they are in fact human cells, and as such they have the innate machinery not only to trick the body's defense and maintenance systems, ...

Oncology & Cancer

Engineering a cancer-fighting virus

Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...

Oncology & Cancer

Melanoma: dabrafenib and trametinib have added benefit

The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with ...

page 1 from 13